Pharmaceutical Technology Europe, Mar 1, 2012 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology Europe, Mar 1, 2012
Special Feature
Single-Use Redundant Filtration
By Ranjeet Patil , Michael Felo , George Oulundsen
The authors describe a new assembly for bulk and final drug product filling operations.
Peer-Reviewed Research
Evaluating Impurities in Drugs (Part II of III)
In Part II of a three-part article, the authors examine impurities from chiral molecules, polymorphic contaminants, and genotoxic impurities.
Industry Insider
Stepping Up the Fight Against Counterfeits
By Nathan Jessop
Traditionally more prevalent in less industrialised regions, counterfeit medicines are now more frequently entering the heavily regulated supply chains of EU countries.
Outsourcing Review
CMOs Face a Kodak Moment
The evolving bio/pharmaceutical business model poses risk for CMOs.
Ask the Expert
Parametric release and real-time release testing
By Heribert Häusler
Boehringer Ingelheim's Heribert Häusler tells us about parametric release and real-time testing.
News
News: Market Boom for Generics
By Stephanie Sutton
The pharma industry has reached the long-dreaded patent cliff, but for copycat products, business is booming.
Ingredients
Securing the Pharma Supply Chain
Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here